Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Captisol enabled furosemide - SQ Innovation

Next Previous
Drug Profile

Captisol enabled furosemide - SQ Innovation

Alternative Names: CE Furosemide; Furesomide 2.0; Lasix ONYU; LASIX®; SQIN-01

Latest Information Update: 12 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SQ Innovation
  • Class Antihypertensives; Heart failure therapies; Skin disorder therapies; Small molecules; Sulfanilamides
  • Mechanism of Action Sodium chloride symporter Inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Chronic heart failure
  • No development reported Heart failure; Oedema

Most Recent Events

  • 27 Feb 2025 SQ Innovation announces intention to launch Captisol enabled furosemide for Chronic heart failure by the end of 2025
  • 31 Oct 2024 Registered for Chronic heart failure in USA (SC) (SQ Innovation website, January 2025)
  • 30 Oct 2024 Preregistration for Chronic heart failure in USA (SC) before October 2024 (SQ Innovation website, January 2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top